Sophie R Cohen

Affiliations: 
Drexel University College of Medicine, Philadelphia, PA, United States 
Area:
Dopamine, DAT, Dopamine Receptors, Motivation, Sleep, PD
Google:
"Sophie Cohen"
Mean distance: (not calculated yet)
 

Parents

Sign in to add mentor
Christopher R. Bishop research assistant 2019-2022 Binghamton University (SUNY)
 (Undergraduate Honors Research)
Rodrigo Espana grad student 2021- Drexel
 (Graduate Training)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Centner A, Del Priore I, Chambers N, et al. (2024) Deficits in basal and evoked striatal dopamine release following alpha-synuclein preformed fibril injection: An in vivo microdialysis study. The European Journal of Neuroscience
Budrow C, Elder K, Coyle M, et al. (2023) Broad Serotonergic Actions of Vortioxetine as a Promising Avenue for the Treatment of L-DOPA-Induced Dyskinesia. Cells. 12
Lipari N, Centner A, Glinski J, et al. (2022) Characterizing the relationship between L-DOPA-induced-dyskinesia and psychosis-like behaviors in a bilateral rat model of Parkinson's disease. Neurobiology of Disease. 105965
Cohen SR, Terry ML, Coyle M, et al. (2022) The multimodal serotonin compound Vilazodone alone, but not combined with the glutamate antagonist Amantadine, reduces l-DOPA-induced dyskinesia in hemiparkinsonian rats. Pharmacology, Biochemistry, and Behavior. 217: 173393
Cohen SR, Terry ML, Coyle, et al. (2022) The multimodal serotonin compound Vilazodone alone, but not combined with the glutamate antagonist Amantadine, reduces l-DOPA-induced dyskinesia in hemiparkinsonian rats Pharmacology, Biochemistry & Behavior. 217: 173393
Smith S, Sergio J, Coyle M, et al. (2022) The effects of Vilazodone, YL-0919 and Vortioxetine in hemiparkinsonian rats. Psychopharmacology
See more...